RESPONSIVENESS OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE-25 TO VISUAL ACUITY GAINS IN PATIENTS WITH DIABETIC MACULAR EDEMA: Evidence From the RIDE and RISE Trials.

Authors:
Suñer IJ; Bressler NM; Varma R; Dolan CM; Ward J and 1 more

Journal:
Retina

Publication Year: 2017

DOI:
10.1097/IAE.0000000000001316

PMCID:
PMC5470864

PMID:
27668928

Journal Information

Full Title: Retina

Abbreviation: Retina

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"I. J. Suñer is a consultant for Bausch & Lomb, Eyetech, Genentech, Optos, and Pfizer and is on the Medical Advisory Board for Optos. N. M. Bressler is the Principal Investigator of grants at The Johns Hopkins University sponsored by the following entities: Bayer HealthCare Pharmaceuticals Inc.; Genentech/Roche; Novartis Pharma AG; Regeneron Pharmaceuticals, Inc; The EMMES Corporation; and the National Institutes of Health. He has an independent contract agreement at The Johns Hopkins University from the American Medical Association. R. Varma is a consultant for Allergan, Aquesys, Genentech, Merck, and Replenish and has received research funding from Genentech, Inc. and Replenish and has an Unrestricted Departmental Grant from the Research to Prevent Blindness, New York, NY. C. M. Dolan and J. Ward are paid consultants for Genentech, Inc. A. Turpcu is an employee of Genentech, Inc."

Evidence found in paper:

"Supported by Genentech, Inc. Support for third-party writing assistance for this manuscript was provided by Genentech, Inc. Medical writing support for this manuscript was provided by Rebecca Jarvis and Emily Howard of Envision Scientific Solutions and was funded by Genentech, Inc."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025